Vassilios Katsos
Director/Board Member bei LAMDA DEVELOPMENT S.A.
Profil
Vassilios Katsos is currently the Chairman, President & CEO of Pharmathen Pharmaceuticals SA, and a Non-executive Director at LAMDA Development SA. He is also the President & Director of Pharmathen International SA, and a Director at Pharmathen Holding 4 Ltd., Pharmathen Global Ltd., Pharmathen Holding 1 Ltd., Pharmathen Holding 2 Ltd., VNK Capital Ltd., and Nadeau Investments Ltd.
Previously, he was the President & Director of Pharmathen SA, and a Director at Dialben Investments Ltd.
He received his undergraduate degree from Pierce College.
Aktive Positionen von Vassilios Katsos
| Unternehmen | Position | Beginn |
|---|---|---|
| LAMDA DEVELOPMENT S.A. | Director/Board Member | - |
Pharmathen Pharmaceuticals SA
 Pharmathen Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Pharmathen Pharmaceuticals SA develops and markets health care products. It manufactures cosmetics and pharmaceutical products and licenses out to the pharmaceutical companies in Europe, Canada, Australia, South Africa and the United States. The firm also distributes products in Africa, Asia, Latin America and the Middle East through a network of agents and distributors. The company was founded by Nicolas Katsos in 1969 and is headquartered in Pallini, Greece. | Chief Executive Officer | - |
Pharmathen International SA
 Pharmathen International SA Pharmaceuticals: MajorHealth Technology Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and is focused on the development and marketing of pharmaceuticals, with a strong position in generics. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution. The company's human resources works in the sectors of Research & Development (R&D), production and distribution of drugs to different countries worldwide. Now, Pharmathen's products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada. | President | - |
Pharmathen Holding 4 Ltd.
 Pharmathen Holding 4 Ltd. Pharmaceuticals: MajorHealth Technology Pharmathen Holding 4 Ltd. is a holding British company that operates through its subsidiaries in the pharmaceutical industry. The private company is involved in the development and marketing of pharmaceutical products. | Director/Board Member | - |
Pharmathen Global Ltd.
 Pharmathen Global Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Pharmathen Holding 4 Ltd., Pharmathen Global Ltd. provides management services. The private company is based in Hertford, UK. | Director/Board Member | - |
Pharmathen Holding 3 Ltd.
 Pharmathen Holding 3 Ltd. Financial ConglomeratesFinance Pharmathen Holding 3 Ltd. is a British investment company founded in 2015. The private company is based in Saint Helier, UK. The company provides investment services. | Director/Board Member | 01.09.2015 |
Pharmathen Holding 2 Ltd.
 Pharmathen Holding 2 Ltd. Financial ConglomeratesFinance Pharmathen Holding 2 Ltd. is an investment holding British company founded in 2015. The private company is based in St. Helier, UK. The company's main function is to hold investments. | Director/Board Member | 01.09.2015 |
Pharmathen Holding 1 Ltd.
 Pharmathen Holding 1 Ltd. Financial ConglomeratesFinance Pharmathen Holding 1 Ltd. provides investment services. The private company is based in Saint Helier, UK. | Director/Board Member | 01.09.2015 |
VNK Capital Ltd.
 VNK Capital Ltd. Financial ConglomeratesFinance VNK Capital Ltd. provides investment services. The private company is based in Limassol, Cyprus. and has subsidiaries in Cyprus. | Corporate Officer/Principal | - |
| ░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Vassilios Katsos
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░ | ░░░░░░░░░ | - |
Ausbildung von Vassilios Katsos
| Pierce College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LAMDA DEVELOPMENT S.A. | Finance |
| Private Unternehmen | 11 |
|---|---|
Pharmathen Pharmaceuticals SA
Pharmathen Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Pharmathen Pharmaceuticals SA develops and markets health care products. It manufactures cosmetics and pharmaceutical products and licenses out to the pharmaceutical companies in Europe, Canada, Australia, South Africa and the United States. The firm also distributes products in Africa, Asia, Latin America and the Middle East through a network of agents and distributors. The company was founded by Nicolas Katsos in 1969 and is headquartered in Pallini, Greece. | Health Technology |
Pharmathen SA
 Pharmathen SA Pharmaceuticals: MajorHealth Technology Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece. | Health Technology |
| Dialben Investments Ltd. | |
Pharmathen International SA
Pharmathen International SA Pharmaceuticals: MajorHealth Technology Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and is focused on the development and marketing of pharmaceuticals, with a strong position in generics. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution. The company's human resources works in the sectors of Research & Development (R&D), production and distribution of drugs to different countries worldwide. Now, Pharmathen's products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada. | Health Technology |
VNK Capital Ltd.
VNK Capital Ltd. Financial ConglomeratesFinance VNK Capital Ltd. provides investment services. The private company is based in Limassol, Cyprus. and has subsidiaries in Cyprus. | Finance |
Pharmathen Holding 4 Ltd.
Pharmathen Holding 4 Ltd. Pharmaceuticals: MajorHealth Technology Pharmathen Holding 4 Ltd. is a holding British company that operates through its subsidiaries in the pharmaceutical industry. The private company is involved in the development and marketing of pharmaceutical products. | Health Technology |
Pharmathen Global Ltd.
Pharmathen Global Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Pharmathen Holding 4 Ltd., Pharmathen Global Ltd. provides management services. The private company is based in Hertford, UK. | Commercial Services |
Pharmathen Holding 1 Ltd.
Pharmathen Holding 1 Ltd. Financial ConglomeratesFinance Pharmathen Holding 1 Ltd. provides investment services. The private company is based in Saint Helier, UK. | Finance |
Pharmathen Holding 2 Ltd.
Pharmathen Holding 2 Ltd. Financial ConglomeratesFinance Pharmathen Holding 2 Ltd. is an investment holding British company founded in 2015. The private company is based in St. Helier, UK. The company's main function is to hold investments. | Finance |
Pharmathen Holding 3 Ltd.
Pharmathen Holding 3 Ltd. Financial ConglomeratesFinance Pharmathen Holding 3 Ltd. is a British investment company founded in 2015. The private company is based in Saint Helier, UK. The company provides investment services. | Finance |
| Nadeau Investments Ltd. |
